NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the grow

		HER2 Support Group Forums > Articles of Interest
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the grow

10-10-2013, 10:45 AM	#1
'lizbeth Senior Member Join Date: Apr 2008 Location: Sunny San Diego Posts: 2,214	Re: NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the http://www.novartisoncology.com/rese...n/pipeline.jsp BEZ235 is in Phase I/II clinical trials in the pipeline at NovartisOncology. There are 50 open trials for breast cancer with Novartis products: http://clinicaltrials.gov/ct2/result...=Open&no_unk=Y

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 08:14 PM.